GLP-1 medications can be effective for weight management because of their appetite-suppressing effects, which may lead to meaningful weight loss over time
To define the molecular basis of the metabolic dysfunction caused by CI loss in adipocytes, we next analysed the transcriptome in visceral WAT
De F.), the Melanoma Research Foundation (Established Investigator award, E.C.De F.), the NIH Shared Instrumentation Grant S10RR025565 and supported in part by the intramural research program of the NCI, NIH and federal funds from the National Cancer Institute, National Institutes of Health, under Contract No
Knop FK, Urva S, Rettinganti M, Benson C, Roell W, Mather KJ, et al
doi: 10.1152/jappl.1993.74.3.1024 23 HanzawaKKuboKKaiMHiragaAWatanabeS
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are widely used in the treatment of type 2 diabetes and potential applications may include the treatment of obesity as well as the adjunctive treatment of type 1 diabetes mellitus in combination with insulin